Lightship Expands Colorado Facility, More Than Quadrupling Manufacturing Capacity
Lightship®, the leading American-made all-electric recreational vehicle (RV) manufacturer, is scaling up to meet surging demand, announcing today a major expansion of its Colorado-based manufacturing facility alongside the launch of a new customization offering, signaling the next phase of growth and reinforcing its commitment to domestic manufacturing.
Lightship Appoints Darcy Forman as Chief Operating Officer to Accelerate Expansion and Operational Excellence
Lightship, a leading provider of community-based, decentralized clinical trial services, is appointing Darcy Forman as Chief Operating Officer (COO). In this key role, Forman will further enhance Lightship’s ability to deliver representative clinical trials at scale, driving operational excellence, and expanding the company’s capacity to handle more complex, decentralized trial solutions in communities across the nation.
Lightship Expands Operations with Colorado Production Facility for First Purpose-built All-electric RV
Lightship, America’s first all-electric RV company, today announced it signed a lease agreement on a 32,000 square-foot facility in Broomfield, Colorado. The space will house the company’s pilot manufacturing operations for the Lightship L1, an aerodynamic, solar and battery-powered travel trailer, to meet high demand following its launch in March.
Announcing the Lightship L1: The First Purpose-built All-electric RV
Lightship, America’s first all-electric recreational vehicle (RV) company, today announced the launch of the Lightship L1 — an aerodynamic, battery-powered travel trailer and the first purpose-built travel trailer with a self-propulsion system that enables near zero range or mile-per-gallon efficiency loss for the vehicle towing it.
Lightship Raises $40 Million to Bring Clinical Trials to Every Patient in Need
Lightship, the leading virtual-first provider of clinical trials, today announced that it has raised $40 million to create access to clinical research for all patients, and improving diversity among patient groups taking part in clinical trials around the world.
